1.090SEK+3.81%Mkt Cap: 10.03M $P/E: —1d ago
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap10.03M $
Enterprise Value5.86M $
Revenue (TTM)1.32M $
Gross Profit1.10M $
Net Income (TTM)-4.15M $
Revenue/Share0.0254 USD
Last Price1.090 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.99
PEG—
EV/EBITDA-1.60
EV/Revenue4.43
P/S7.58
P/B0.66
EPS (TTM)-0.71
EPS (Forward)-1.10
52W Range
0.906010% of range2.790
52W High2.790 SEK
52W Low0.9060 SEK
Profitability
Gross Margin1042.65%
Oper. Margin-188.10%
EBITDA Margin-277.05%
Profit Margin-3925.50%
ROE-36.77%
ROA-33.08%
Growth
Revenue Growth-14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.05M $
CapEx (TTM)1.35M $
FCF Margin-197.18%
FCF Yield-26.02%
Net Debt-4.17M $
Net Debt/EBITDA1.14
Balance Sheet
Debt/Equity0.03
Current Ratio3.70
Quick Ratio3.70
Book Value/Sh1.640 SEK
Cash/Share0.5120 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.8000 SEK
Upside (mean)-26.6%
Target Range0.8000 SEK – 0.8000 SEK
# Analysts1
Ownership
Shares Out.96.17M
Float92.60M
Insiders48.90%
Institutions34.06%
Technical
SMA 501.146 (-4.9%)
SMA 2001.274 (-14.4%)
Beta0.39
S&P 52W Chg19.63%
Avg Vol (30d)48.49K
Avg Vol (10d)45.09K
Technical Indicators
RSI (14)48.0
MACD-0.0214
MACD Signal-0.0249
MACD Hist.+0.0034
BB Upper1.173 SEK
BB Middle1.085 SEK
BB Lower0.9970 SEK
BB Width16.21%
ATR (14)0.0585 SEK
Vol Ratio (20d)0.30x